The Indian market has been flat over the last week but has shown a robust 40% increase over the past year, with earnings anticipated to grow by 17% annually in the coming years. In this thriving environment, identifying growth stocks with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the company and potential for continued revenue expansion.
Name | Insider Ownership | Earnings Growth |
Archean Chemical Industries (NSEI:ACI) | 22.9% | 34% |
Kirloskar Pneumatic (BSE:505283) | 30.3% | 30.1% |
Jupiter Wagons (NSEI:JWL) | 10.8% | 27.4% |
Dixon Technologies (India) (NSEI:DIXON) | 24.6% | 30.8% |
Paisalo Digital (BSE:532900) | 16.3% | 24.8% |
Apollo Hospitals Enterprise (NSEI:APOLLOHOSP) | 10.4% | 32.3% |
Rajratan Global Wire (BSE:517522) | 18.3% | 35.8% |
KEI Industries (BSE:517569) | 19.2% | 21.9% |
Pricol (NSEI:PRICOLLTD) | 25.5% | 24% |
Aether Industries (NSEI:AETHER) | 31.1% | 45.8% |
Underneath we present a selection of stocks filtered out by our screen.
Simply Wall St Growth Rating: ★★★★★☆
Overview: Apollo Hospitals Enterprise Limited, along with its subsidiaries, provides healthcare services in India and internationally, with a market cap of ₹1.02 trillion.
Operations: The company's revenue is derived from Healthcare Services at ₹102.83 billion, Retail Health & Diagnostics at ₹14.12 billion, and Digital Health & Pharmacy Distribution at ₹81.04 billion.
Insider Ownership: 10.4%
Revenue Growth Forecast: 16.2% p.a.
Apollo Hospitals Enterprise demonstrates strong growth potential with earnings forecasted to increase significantly at 32.28% annually over the next three years, outpacing the Indian market's growth rate. Recent financial performance showed a substantial rise in net income to ₹3.05 billion for Q1 2024, compared to ₹1.67 billion a year ago, reflecting robust operational efficiency despite high debt levels. The company's insider ownership aligns management interests with shareholders, enhancing confidence in its strategic direction and long-term prospects.
Simply Wall St Growth Rating: ★★★★★★
Overview: Dixon Technologies (India) Limited provides electronic manufacturing services both domestically and internationally, with a market capitalization of ₹913.41 billion.
Operations: The company's revenue segments include Home Appliances at ₹12.51 billion, Lighting Products at ₹7.92 billion, Mobile & EMS Division at ₹143.16 billion, and Consumer Electronics & Appliances at ₹41.21 billion.
Insider Ownership: 24.6%
Revenue Growth Forecast: 23.7% p.a.
Dixon Technologies (India) exhibits strong growth prospects with earnings expected to rise significantly at 30.8% annually over the next three years, surpassing the Indian market growth rate. Recent financial results highlight a substantial increase in net income to ₹1.34 billion for Q1 2024, doubling from a year ago, indicating effective management and operational efficiency. High insider ownership suggests aligned interests between management and shareholders, supporting confidence in its strategic initiatives and future growth trajectory.
Simply Wall St Growth Rating: ★★★★★☆
Overview: Varun Beverages Limited, along with its subsidiaries, serves as a franchisee for carbonated soft drinks and non-carbonated beverages under PepsiCo trademarks, with a market cap of ₹1.92 trillion.
Operations: The company's revenue from manufacturing and selling beverages amounts to ₹180.52 billion.
Insider Ownership: 36.2%
Revenue Growth Forecast: 15.4% p.a.
Varun Beverages is poised for robust growth with earnings projected to expand significantly at 22.4% annually, outpacing the Indian market. The company plans to raise ₹75 billion through a Qualified Institutional Placement to fund expansions and reduce debt, indicating strategic financial management. Recent investments in a Pepsi production facility in DRC highlight its international growth ambitions. High insider ownership aligns management interests with shareholders, bolstering confidence in its growth strategy.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com